Vimian Group AB (publ) (STO: VIMIAN)

Sweden flag Sweden · Delayed Price · Currency is SEK
45.00
+0.15 (0.33%)
Dec 2, 2024, 5:29 PM CET
76.82%
Market Cap 23.54B
Revenue (ttm) 3.99B
Net Income (ttm) 2.90M
Shares Out 523.20M
EPS (ttm) 0.00
PE Ratio 8,130.24
Forward PE 36.33
Dividend n/a
Ex-Dividend Date n/a
Volume 1,531,491
Open 44.70
Previous Close 44.85
Day's Range 44.25 - 45.70
52-Week Range 24.64 - 47.20
Beta 1.62
Analysts n/a
Price Target n/a
Earnings Date Feb 13, 2025

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the I... [Read more]

Sector Healthcare
Founded 2020
Employees 1,100
Stock Exchange Nasdaq Stockholm
Ticker Symbol VIMIAN
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.